Project Grant R01AG079944

Award Date 7/1/24
Completion Date 3/31/29
Dollars Obligated $2.4M
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
NEWCOMB HALL, VA 22904, USA
Similar Awards
This Project Grant award of $395,796 from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research at Brown University to develop genetic, pharmacological, and dietary interventions that delay the onset and progression of age-related diseases. The key objectives are to: 1) Investigate the interconnectedness and hierarchical structure of the hallmarks of aging, such as loss of genomic integrity, activation of retrotransposons, and accumulation of lipid droplets; 2)...
This $1,044,855 Project Grant from the National Institute on Aging, part of the Department of Health and Human Services, will fund Nemalife Inc. to deliver high-throughput testing of anti-aging and FDA-approved drugs in genetically diverse invertebrate Alzheimer's disease models. Under the Aging Research program (CFDA 93.866), the awardee will screen 300 anti-aging compounds and 200 FDA drugs to identify candidates that improve neuronal aging and protect against protein misfolding diseases...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $196,460 to Rockefeller University to conduct structural and functional characterization of the mRNA export platform in Saccharomyces cerevisiae (baker's yeast). The primary goals are to generate a high-resolution integrative model of the mRNA export platform using cryo-EM, biochemistry, and computational methods, and to investigate how aging-associated mutations disrupt the platform's...
This Project Grant award of $506,404.00 was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) to investigate mechanisms of local and global epigenetic changes that drive senescence and aging-associated phenotypes. Key research objectives include: Examining how enhancers are rewired during senescence and aging, focusing on large enhancer communities or "cliques" and identifying transcription factors that drive their formation....
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $236,918 to the University of Virginia to characterize the ketogenesis pathway in the budding yeast Saccharomyces cerevisiae and investigate the potential longevity benefits of the ketone body metabolite β-hydroxybutyrate (BHB). The award aims to develop yeast as a novel genetic system for studying the role of BHB in lifespan regulation, building on the researchers' unexpected discovery of...
The Research Foundation of the City University of New York (RFCUNY), acting as the fiscal administrator for the City University of New York (CUNY), has received a $458,510 Project Grant award from the National Institute on Aging under the Aging Research program (CFDA 93.866). This award will support the development of a transformative deep learning framework to integrate multi-omics data and elucidate the molecular mechanisms underlying exceptional longevity (EL). The key objectives are to: 1)...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of California, San Francisco (UCSF) provides $1,682,833 to study human-specific vulnerabilities and compensatory adaptations to age-related stressors in midbrain dopaminergic neurons. The primary goals are to: Measure dynamic gene regulatory responses and candidate protective pathways to age-related oxidative stress in human, chimpanzee, and rhesus macaque dopaminergic neurons using...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $416,625.00 to Saint Louis University to conduct research on "Targeted Modulation of Longevity-Associated Genes Using Antisense Oligonucleotides." The project aims to: 1) design and test antisense oligonucleotides to modulate the levels of four longevity-associated genes, and 2) test if the antisense oligonucleotides can extend lifespan and improve healthspan using a mouse...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $2,149,861 to the Albert Einstein College of Medicine to investigate the relationship between clonal hematopoiesis (CH), aging, and exceptional longevity. The key objectives are to: Determine the prevalence and mutational spectrum of CH and its association with age-related diseases in populations with exceptional longevity, comparing centenarians, their offspring, and age/sex-matched...
The federal Project Grant award R01AG086692 was provided by the National Institute on Aging (NIA) under the Aging Research grant program (CFDA 93.866) to Brandeis University. The $331,187 award will fund a 4-year study to understand the role of retrotransposon activity in aging and age-related phenotypes using the Drosophila model system. The goals of the project are to characterize a Drosophila system to determine whether transposon activity is a cause or effect of the aging process. This...

UNDERSTANDING OF ESSENTIAL GENE FUNCTION IN AGING - PROJECT SUMMARY FUNCTIONAL GENOMIC STUDIES HAVE CONTRIBUTED ENORMOUSLY TO OUR UNDERSTANDING OF CONSERVED GENETIC PATHWAYS INFLUENCING AGING IN EVOLUTIONARILY DIVERGENT ORGANISMS. THE USE OF HIGH THROUGHPUT MACHINERY AND THE APPLICATION OF SKILLED MANPOWER ALONG WITH SCREENING SYSTEMATIC GENE KNOCK-OUT IN YEAST AND GENE DEPLETION (RNA INTERFERENCE) IN WORM HAVE LED TO THE IDENTIFICATION OF SEVERAL GENES THAT INFLUENCE LIFE SPAN. SOME OF THESE GENES HAVE HUMAN ORTHOLOGUES AND HAVE BEEN EXAMINED SUCCESSFULLY IN THE CONTEXT OF INVERTEBRATE AND MAMMALIAN AGING. ALTHOUGH, IT IS NOW CLEAR THAT AT LEAST SOME ASPECTS OF CELLULAR AGING ARE HIGHLY CONSERVED, IDENTIFICATION OF CONSERVED COMPONENTS OF LONGEVITY PATHWAYS ACROSS EVOLUTIONARILY DIVERGENT ORGANISMS HAS LAGGED FAR BEHIND. WE WILL ADDRESS THIS ISSUE BY ANALYZING THE FUNCTION OF CONSERVED ESSENTIAL GENES IN REGULATION OF LONGEVITY. ESSENTIAL GENES IN YEAST ARE APPROXIMATELY 5 TIMES MORE LIKELY TO HAVE HUMAN ORTHOLOGS THAN NON-ESSENTIAL GENES. FOR EXAMPLE, AMONG THE 1123 YEAST ESSENTIAL GENES, 856 OF THEM HAVE BOTH WORM AND HUMAN HOMOLOGS. HOWEVER, TO DATE, DESPITE THE GREATER FUNCTIONAL IMPORTANCE AND HIGH CONSERVATION BETWEEN SPECIES, THERE HAS BEEN NO COMPREHENSIVE STUDY TO CHARACTERIZE THE ROLE OF ESSENTIAL GENES IN AGING. ACCORDINGLY, THE GOAL OF THIS PROPOSAL IS TO TEST THE HYPOTHESIS THAT ESSENTIAL GENETIC MODIFIERS OF AGING IN YEAST ARE MORE LIKELY TO PLAY A CONSERVED ROLE IN THE AGING PROCESS IN MULTICELLULAR EUKARYOTES. IN A COMPLETE SCREEN OF YEAST AND VALIDATION SCREEN FROM WORM STRAINS WITH INCREASED EXPRESSION OF ONE THE ESSENTIAL GENES FOR WHICH THERE IS A CLEAR HUMAN ORTHOLOG, WE MADE THE STRIKING OBSERVATION THAT ESSENTIAL GENES ARE MUCH MORE LIKELY THAN NON-ESSENTIAL GENES TO PLAY AN IMPORTANT CONSERVED ROLE IN LIFESPAN REGULATION. WE PROPOSE TO USE RECENTLY DEVELOPED TOOLS TO SCREEN THE CONSERVED GENE DOSAGE EFFECT ON LIFESPAN USING C. ELEGANS (AIM 1). NEXT, WE WILL IDENTIFY GENETIC MECHANISMS OF LIFESPAN DETERMINATION BY ANALYZING GENOME-SCALE PATTERNS OF AGE-ASSOCIATED MRNA EXPRESSION CHANGES IN LONG LIVING STRAINS AND PLACE NEW LONGEVITY GENES INTO OR OUT OF KNOWN LONGEVITY PATHWAYS WITH GENETIC EPISTASIS EXPERIMENTS (AIM 2). IN THE LAST AIM, WE WILL PROVIDE PROOF OF MECHANISTIC CONCEPT BY INVESTIGATING THE MOLECULAR MECHANISMS UNDERLYING A PROMISING, POTENTIALLY CONSERVED IN HUMANS, MODE OF LONGEVITY STEMMING FROM THE OVEREXPRESSION OF CONSERVED ESSENTIAL GENES (AIM 3). SUCH GENES ARE A RICH, UNTAPPED SOURCE FOR UNDERSTANDING GENETIC MECHANISMS OF LONGEVITY DETERMINATION. THUS, EVERY HIT REPRESENTS A NEWLY DISCOVERED LONGEVITY GENE WITH A CONSERVED HUMAN ORTHOLOG. SUCCESSFUL COMPLETION OF THIS PROPOSAL WILL YIELD A WEALTH OF NEW INFORMATION ABOUT CONSERVED MECHANISMS OF MOLECULAR DETERMINATION OF AGING AND WILL IDENTIFY DOZENS OF CANDIDATE GENES FOR TESTING IN HIGHER EUKARYOTES WITH IMPORTANT RAMIFICATIONS FOR HEALTHY HUMAN AGING.

Posted 6/26/24, 12:00 AM